1. Home
  2. EVI vs AVXL Comparison

EVI vs AVXL Comparison

Compare EVI & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EVI Industries Inc.

EVI

EVI Industries Inc.

HOLD

Current Price

$20.75

Market Cap

272.8M

ML Signal

HOLD

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$3.40

Market Cap

289.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVI
AVXL
Founded
1959
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
272.8M
289.1M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
EVI
AVXL
Price
$20.75
$3.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$35.00
$22.00
AVG Volume (30 Days)
23.8K
2.0M
Earning Date
05-11-2026
05-12-2026
Dividend Yield
1.55%
N/A
EPS Growth
32.43
N/A
EPS
0.26
N/A
Revenue
$389,830,000.00
N/A
Revenue This Year
$15.53
N/A
Revenue Next Year
$3.83
N/A
P/E Ratio
$81.85
N/A
Revenue Growth
10.26
N/A
52 Week Low
$14.99
$2.61
52 Week High
$34.82
$13.99

Technical Indicators

Market Signals
Indicator
EVI
AVXL
Relative Strength Index (RSI) 45.47 47.74
Support Level $20.33 $2.93
Resistance Level $21.52 $4.88
Average True Range (ATR) 1.06 0.18
MACD 0.00 0.06
Stochastic Oscillator 20.05 98.62

Price Performance

Historical Comparison
EVI
AVXL

About EVI EVI Industries Inc.

EVI Industries Inc is a value-added distributor and service provider in the commercial laundry industry. It sells and leases commercial laundry equipment, specializing in washing, drying, finishing, material handling, water heating, power generation, and water reuse applications. The company supports its equipment offerings with installation, maintenance, and repair services through a large network of trained technicians. It serves a wide range of customers, including commercial, industrial, institutional, government, and retail sectors. Geographically, the company serves various countries including United States, Canada, the Caribbean, and Latin America.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: